New hope for kids with severe bleeding disorder: advanced treatment shows promise

NCT ID NCT04759131

Summary

This study tested a new, long-acting factor VIII replacement drug called BIVV001 in children under 12 with severe hemophilia A. The main goal was to see if it was safe and effective at preventing and treating bleeding episodes over a year of treatment. Researchers also looked at how it affected joint health, quality of life, and its use during surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Healthcare of Atlanta-Site Number:8400019

    Atlanta, Georgia, 30322, United States

  • Children's Hospital Los Angeles-Site Number:8400006

    Los Angeles, California, 90027, United States

  • Children's Hospital Of Wisconsin-Site Number:8400005

    Milwaukee, Wisconsin, 53226-0509, United States

  • Childrens Hospital Of Columbus-Site Number:8400012

    Columbus, Ohio, 43205, United States

  • Cincinnati Children's Hospital Medical Center-Site Number:8400008

    Cincinnati, Ohio, 45206, United States

  • East Carolina University/Brody Medical Sciences Building-Site Number:8400015

    Greenville, North Carolina, 27834, United States

  • Investigational Site Number :0360001

    Westmead, New South Wales, 2145, Australia

  • Investigational Site Number :0360002

    South Brisbane, Queensland, 4101, Australia

  • Investigational Site Number :1240001

    Toronto, Ontario, M5G 1X8, Canada

  • Investigational Site Number :1240002

    Ottawa, Ontario, K1H 8L1, Canada

  • Investigational Site Number :1240003

    London, Ontario, N6A 4G5, Canada

  • Investigational Site Number :1240004

    Hamilton, Ontario, L8N 3Z5, Canada

  • Investigational Site Number :1580001

    Taichung, 402, Taiwan

  • Investigational Site Number :1580002

    Taipei, 10002, Taiwan

  • Investigational Site Number :1580003

    Taichung, 407, Taiwan

  • Investigational Site Number :1580004

    Taipei, 11031, Taiwan

  • Investigational Site Number :2500001

    Le Kremlin-Bicêtre, 94275, France

  • Investigational Site Number :2500003

    Lille, 59037, France

  • Investigational Site Number :2500004

    Bron, 69500, France

  • Investigational Site Number :2760001

    Frankfurt am Main, 60590, Germany

  • Investigational Site Number :2760002

    München, 80337, Germany

  • Investigational Site Number :3480005

    Pécs, 7623, Hungary

  • Investigational Site Number :3720001

    Dublin, D12 N512, Ireland

  • Investigational Site Number :3800001

    Milan, 20121, Italy

  • Investigational Site Number :3800002

    Naples, 80123, Italy

  • Investigational Site Number :5280001

    Utrecht, 3584 CX, Netherlands

  • Investigational Site Number :5280002

    Amsterdam, 1105 AZ, Netherlands

  • Investigational Site Number :7240001

    Madrid, Madrid, Comunidad de, 28046, Spain

  • Investigational Site Number :7240002

    Esplugues de Llobregat, Catalunya [Cataluña], 08950, Spain

  • Investigational Site Number :7520001

    Malmo, 20502, Sweden

  • Investigational Site Number :7560001

    Zurich, 8032, Switzerland

  • Investigational Site Number :7920001

    Istanbul, 34390, Turkey (Türkiye)

  • Investigational Site Number :7920003

    Izmir, TR-35100, Turkey (Türkiye)

  • Investigational Site Number :7920004

    Antalya, 07059, Turkey (Türkiye)

  • Investigational Site Number :8260001

    London, WC1N3JH, United Kingdom

  • Investigational Site Number :8260003

    Birmingham, B4 6NH, United Kingdom

  • NY Presbyterian - Weill Cornell Medical Center-Site Number:8400020

    New York, New York, 10021, United States

  • Rush University Medical Center-Site Number:8400001

    Chicago, Illinois, 60612-3833, United States

  • University of Florida-Site Number:8400009

    Gainesville, Florida, 32610, United States

  • University of Iowa Hospitals and Clinics-Site Number:8400002

    Iowa City, Iowa, 52242, United States

Conditions

Explore the condition pages connected to this study.